Company: FEAV
Filing Date: 2025-01-17
Form Type: DEFA14A
Source: 0000950170-25-006729
Chunk: 8

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-01-17
Form: DEFA14A
Chunk 8
---
 commitment is an excellent thing for us for the longer term. So I think we're into, we get into a fundamentally much better position. It does come with some level of pain right now, which we appreciate, but we think it's ultimately, it's the right thing going forward.

Romeo Maione

6ix

Thanks for additional context. The next question. It's echoed by Adrian in the chat, which is how far do the funds from equitization and the additional equity purchases take you in terms of operations and advancing pre feed engineering? So really, with the new capital, how long of a timeline is this fund based on anticipated burn rate?

Paul Weibel

CEO

Great. Thanks for the question. Appreciate the activity in the chat. So the first part of the funding package will give us runway to complete for pre feed engineering. There was a, you know, when we kind of announced that the byproducts going to be calcium chloride that did push out pre feed a bit into a little bit later in the spring.

So it gets us us through that. We think that the move to calcium chloride, it's an industrial mineral. It's a better product to sell than gypsum. We've gotten that feedback already as we're talking to various groups. So it gets us through pre feed pfs, all the vendor testing, you know really getting that builds and kind of stage gaze gates over into the file three and the equitization also eliminates those cash covenants and kind of onerous rules that come with with the notes and it could keep us running until June.

Um, you know, and I think that kind of harmoniously aligns with, you know, I expect we'll be at a point where we can stage gate to file three technical report will be in the market. And then obviously the warrants then provide an additional pathway to continue funding the business. And we believe, you know, the exercise of the warrants fully funds the company FID.

So I think this, yes, there's optionality with the warrants, but it's a tool in the toolbox and essentially with Bluescape and Ascend are, are essentially financial partners.

Romeo Maione

6ix

Thank you. Uh, next question also reflected in the chat. This is given the current price level and the volume of new shares. We have to do anything like a reverse split to cure issues with the NASDAQ. And if so, what does, what does that look like?

Paul Weibel